In situ Generated (212)Pb-PSMA Ligand in a (224)Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-Positive Cells

Background: New treatments combating bone and extraskeletal metastases are needed for patients with metastatic castration-resistant prostate cancer. The majority of metastases overexpress prostate-specific membrane antigen (PSMA), making it an ideal candidate for targeted radionuclide therapy. Objec...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Curr Radiopharm
Asıl Yazarlar: Stenberg, Vilde Y., Juzeniene, Asta, Bruland, Øyvind S., Larsen, Roy H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Bentham Science Publishers 2020
Konular:
Pediatric
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7527546/
https://ncbi.nlm.nih.gov/pubmed/32389119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874471013666200511000532
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller